Controversial Cases in Hematologic Malignancies
and Hematology 2014
April 11–12, 2014 • Friday–Saturday
The Colonnade Hotel, Boston, MA



COURSE DESCRIPTION

This interactive, case-focused course is designed to address challenges faced by community specialists in hematology/oncology, answer your questions, and provide a focused update on current best practices in hematologic malignancies and hematology. Each topic will include a representative case, short didactic presentation and opportunity for discussion, all supported by audience response to facilitate interaction and learning. Registered participants will have an opportunity to submit cases prior to the meeting. A special evening learning session is also offered for ABIM Hematology Maintenance of Credit. Faculty drawn from Harvard and other leading institutions will be available for small group discussion during breaks and lunches.

LEARNING OBJECTIVES

Upon completion of this course, participants will be able to:

  • Analyze new agents in hematologic malignancies and hematology and their application in practice
  • Develop strategies to apply optimal therapy and care algorithms to select chemotherapy and biologic therapy in hematologic malignancies
  • Assess and manage complex hematologic problems

WHO SHOULD ATTEND

Physicians, Nurse Practitioners, Physician Assistants, Nurses

ACCREDITATION

The Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Harvard Medical School designates this live activity for a maximum of 11.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

PROGRAM SCHEDULE*

FRIDAY, APRIL 11, 2014
12:00-12:15 PM Registration
12:15-12:30 PM Welcoming Remarks
Program Directors
BENIGN HEMATOLOGY
Session Leader Annemarie E Fogerty, MD
12:30-1:15 PM Diagnosing and Treating Thrombocytopenia in the CA Patient
David J Kuter, MD, PhD, MGH Cancer Center
1:15-1:45 PM Transfusion Medicine for the Hematologist/Oncologist
Sunny Dzik, MD, MGH Cancer Center
1:45-2:15 PM Thrombosis Management Cases
Jean Marie Connors, MD, Brigham and Women's Hospital
2:15-2:30 PM Break
2:30-3:00 PM Challenging Consults
Annemarie E Fogerty, MD, MGH Cancer Center
3:00-3:45 PM Discussion and Q&A
Dr. Fogerty with Drs. Dzik and Connors
3:45-4:30 PM Health Care Management in the Era of Payment Reform
Paul E Mendis, MD, Neighborhood Health Plan
4:30-5:30 PM Reception and open discussion
5:30-7:30 PM ABIM MOC Learning Session: Hematology
Drs. Ballen, Fogerty and Hochberg
SATURDAY, APRIL 12, 2014
7:30-8:00 AM Continental Breakfast
LYMPHOID MALIGNANCIES
Session Leader Ephraim P Hochberg, MD
8:00-9:00 AMTreatment of Myeloproliferative Neoplasms
Ruben Mesa, MD, Mayo Clinic
9:00-10:00 AM T-cell Lymphoma
Andrew M Evens, DO, Tufts University
10:00-10:15 AMBreak
10:15-10:45 AM Hodgkin Lymphoma
Jeffrey A Barnes, MD, PhD, MGH Cancer Center
10:45-11:15 AM Diffuse Large B Cell Lymphoma
Ephraim P Hochberg, MD, MGH Cancer Center
11:15-12:00 PM CLL and Mantle Cell Lymphoma
Jeremy S Abramson, MD, MGH Cancer Center
12:00-12:30 PM Discussion and Q&A
Dr. Hochberg with Drs. Mesa, Evens, Barnes and Abramson
12:30-1:15 PM Lunch breakout sessions with faculty
MYELOID DISEASES AND MYELOMA
Session Leader Karen K Ballen, MD
1:15-2:00 PMMyelodysplastic Syndrome
Tim Graubert, MD and Eyal C Attar, MD, MGH Cancer Center
2:00-3:00 PMChronic Myelogenous Leukemia
Hagop M. Kantarjian, MD, MD Anderson Cancer Center
3:00-3:15 PM Break
3:15-3:45 PM MGUS and Smoldering Myeloma: To treat or not to treat?
Noopur S Raje, MD, MGH Cancer Center
3:45-4:30 PMThe Emerging Role of Novel Therapies in the
Treatment of Multiple Myeloma
Paul Richardson, MD, Dana-Farber Cancer Institute
4:30-5:00 PMDiscussion and Q&A
Dr. Ballen with Drs. Graubert, Attar, Kantarjian, Raje and Richardson
5:00 PMProgram Adjourns
CASE PRESENTATIONS WILL UTILIZE AN AUDIENCE RESPONSE SYSTEM

*Program changes/substitutions may be made without notice.

REGISTRATION INFORMATION



Course Number #3424481

Physicians Fee: $300 (USD)
Residents and Fellows in Training/Allied Health Professional Fee: $200 (USD)

PAYMENT INFORMATION

All foreign payments must be made by a draft on a United States Bank or by Visa or MasterCard.

If paying by check (draft on a United States bank), please make payable to Harvard Medical School and mail with registration form to Harvard Medical School - Department of Continuing Education, PO Box 417476, Boston, MA 02241-7476. Telephone or fax registration is not accepted. Registration with cash payment is not permitted.

If paying by credit card, please register online.

Telephone, fax or mail-in registration with credit card payment is not accepted.

Inquiries should be directed to the above address, made by phone: (617) 384‑8600, Monday ‑ Friday, 10 AM to 4 PM (EST), or by email: hms‑cme@hms.harvard.edu

Upon receipt of your registration form an email confirmation from the HMS-DCE office will be sent to you. Therefore, be sure to include an email address that you check daily/frequently. Your email address is used for critical information about the course including: registration confirmation, course evaluation and certificate.

ACGME COMPETENCIES

This course is designed to meet one or more of the following Accreditation Council of Graduate Medical Education competencies:

  • Patient Care
  • Medical Knowledge
  • Practice-based Learning and Improvement

DISCLOSURE POLICY

Harvard Medical School (HMS) adheres to all ACCME Essential Areas, Standards, and Policies. It is HMS's policy that those who have influenced the content of a CME activity (e.g. planners, faculty, authors, reviewers and others) disclose all relevant financial relationships with commercial entities so that HMS may identify and resolve any conflicts of interest prior to the activity. These disclosures will be provided in the activity materials along with disclosure of any commercial support received for the activity. Additionally, faculty members have been instructed to disclose any limitations of data and unlabeled or investigational uses of products during their presentations.

TUITION REFUND POLICY

A handling fee of $60 is deducted for cancellation. Refund requests must be received by postal mail, email or fax one week prior to this activity. No refunds will be made thereafter.

COURSE LOCATION

All sessions for this course will be held at The Colonnade Hotel, 120 Huntington Ave, Boston, MA 02116.

ACCOMMODATIONS

A limited number of rooms have been reserved at The Colonnade Hotel
(Telephone: 617-424-7000) until March 21, 2014.

TRAVEL

Please do not purchase non-refundable airline ticket(s) until you have received an email from our office confirming your paid registration. For airline reservations contact the HMS Travel Desk toll free 1-877-4-HARVMD (1-877-442-7863) Monday - Friday 9 AM - 8 PM (EST). From outside the U.S., Canada and Virgin Islands, please call 617-559-3764.



Course #3424481





Offered by
Massachusetts General Hospital Cancer Center

Course Directors
Karen Ballen, MD
Annemarie Fogerty, MD
Ephraim Hochberg, MD

No time to register now? Add your name to the mailing list to receive future notices about this course!

FACULTY

JEREMY S ABRAMSON, MD

EYAL C ATTAR, MD

KAREN BALLEN, MD

JEFFREY A BARNES, MD, PHD

JEAN MARIE CONNORS, MD

SUNNY DZIK, MD

ANDREW M EVENS, DO

ANNEMARIE E FOGERTY, MD

TIM GRAUBERT, MD

EPHRAIM HOCHBERG, MD

HAGOP M. KANTARJIAN, MD

DAVID J KUTER, MD, PHD

PAUL E MENDIS, MD

RUBEN MESA, MD

NOOPUR S RAJE, MD

PAUL RICHARDSON, MD


  Copyright © 2013, Harvard Medical School, Department of Continuing Education
    Last update 11.13.2013